Pieter Hoekstra

Pieter Hoekstra

The complete DNA test is an important step toward treating forms of cancer that currently cannot be treated with targeted drugs.

Back to news

More news

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

10-08-2022

Source: website Netherlands Cancer Institute With the rapidly expanding tableau of (increasingly tumor-agnostic) targeted therapies, genome-driven cancer care has become …

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

10-08-2021

A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be …

Hartwig tools now available as a nextflow nf-core pipeline called oncoanalyser 

Hartwig tools now available as a nextflow nf-core pipeline called oncoanalyser 

30-08-2024

The University of Melbourne Centre for Cancer Research (UMCCR) Genomics Platform Group, led by Professor Oliver Hofmann, has collaborated with …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl